1. Home
  2. GPRO vs AARD Comparison

GPRO vs AARD Comparison

Compare GPRO & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoPro Inc.

GPRO

GoPro Inc.

HOLD

Current Price

$1.36

Market Cap

119.4M

ML Signal

HOLD

Logo Aardvark Therapeutics Inc.

AARD

Aardvark Therapeutics Inc.

HOLD

Current Price

$5.29

Market Cap

107.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPRO
AARD
Founded
2004
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
119.4M
107.7M
IPO Year
2014
2025

Fundamental Metrics

Financial Performance
Metric
GPRO
AARD
Price
$1.36
$5.29
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
★ $15.29
AVG Volume (30 Days)
★ 71.8M
112.1K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 79.08
43.11
EPS
★ N/A
N/A
Revenue
★ $651,542,000.00
N/A
Revenue This Year
$23.14
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.57
$3.35
52 Week High
$2.73
$17.94

Technical Indicators

Market Signals
Indicator
GPRO
AARD
Relative Strength Index (RSI) 59.91 44.22
Support Level $0.63 $4.71
Resistance Level $1.57 $5.95
Average True Range (ATR) 0.10 0.47
MACD -0.03 0.02
Stochastic Oscillator 27.50 51.12

Price Performance

Historical Comparison
GPRO
AARD

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.

About AARD Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Share on Social Networks: